Found: 30
Select item for more details and to access through your institution.
Adjuvant and neoadjuvant chemotherapy for biliary tract cancer: a review of randomized controlled trials.
- Published in:
- Japanese Journal of Clinical Oncology, 2023, v. 53, n. 11, p. 1019, doi. 10.1093/jjco/hyad103
- By:
- Publication type:
- Article
A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT).
- Published in:
- Japanese Journal of Clinical Oncology, 2018, v. 48, n. 4, p. 392, doi. 10.1093/jjco/hyy004
- By:
- Publication type:
- Article
Association of the Low-density Lipoprotein Cholesterol/ High-density Lipoprotein Cholesterol Ratio with Glecaprevir-pibrentasvir Treatment.
- Published in:
- Internal Medicine, 2021, v. 60, n. 21, p. 3369, doi. 10.2169/internalmedicine.7098-21
- By:
- Publication type:
- Article
Phase I study on the safety, pharmacokinetic profile, and efficacy of the combination of TSU-68, an oral antiangiogenic agent, and S-1 in patients with advanced hepatocellular carcinoma.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 5, p. 928, doi. 10.1007/s10637-014-0109-2
- By:
- Publication type:
- Article
Feasibility study of postoperative adjuvant chemotherapy with S-1 in patients with biliary tract cancer.
- Published in:
- International Journal of Clinical Oncology, 2018, v. 23, n. 5, p. 894, doi. 10.1007/s10147-018-1283-6
- By:
- Publication type:
- Article
ASO Author Reflections: Characteristics of Surgery for Biliary Tract Cancer that Should be Considered During the Design of Future Clinical Trials.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 12, p. 7384, doi. 10.1245/s10434-023-13922-5
- By:
- Publication type:
- Article
A Multicenter Survey on Eligibility for a Randomized Phase III Trial of Adjuvant Chemotherapy for Resected Biliary Tract Cancer (JCOG1202, ASCOT).
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 12, p. 7331, doi. 10.1245/s10434-023-13913-6
- By:
- Publication type:
- Article
Long-term survival and prognosis associated with conversion surgery in patients with metastatic gastric cancer.
- Published in:
- Molecular & Clinical Oncology, 2017, v. 6, n. 2, p. 163, doi. 10.3892/mco.2017.1128
- By:
- Publication type:
- Article
Rare case of idiopathic sclerosing cholangitis, which was difficult to distinguish from cholangiocarcinoma: A case report.
- Published in:
- Experimental & Therapeutic Medicine, 2018, v. 16, n. 6, p. 5224, doi. 10.3892/etm.2018.6832
- By:
- Publication type:
- Article
Everolimus for Advanced Pancreatic Neuroendocrine Tumours: A Subgroup Analysis Evaluating Japanese Patients in the RADIANT-3 Trial.
- Published in:
- Japanese Journal of Clinical Oncology, 2012, v. 42, n. 10, p. 903, doi. 10.1093/jjco/hys123
- By:
- Publication type:
- Article
Transcatheter Arterial Infusion Chemotherapy with a Fine-powder Formulation of Cisplatin for Advanced Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization.
- Published in:
- Japanese Journal of Clinical Oncology, 2011, v. 41, n. 6, p. 770, doi. 10.1093/jjco/hyr037
- By:
- Publication type:
- Article
A Phase I/II Study of Combined Chemotherapy with Mitoxantrone and Uracil/Tegafur for Advanced Hepatocellular Carcinoma.
- Published in:
- Japanese Journal of Clinical Oncology, 2011, v. 41, n. 3, p. 328, doi. 10.1093/jjco/hyq219
- By:
- Publication type:
- Article
Cisplatin and Etoposide as First-line Chemotherapy for Poorly Differentiated Neuroendocrine Carcinoma of the Hepatobiliary Tract and Pancreas.
- Published in:
- Japanese Journal of Clinical Oncology, 2010, v. 40, n. 4, p. 313, doi. 10.1093/jjco/hyp173
- By:
- Publication type:
- Article
Prognostic Factors in Patients with Gemcitabine-Refractory Pancreatic Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2007, v. 37, n. 2, p. 114, doi. 10.1093/jjco/hyl144
- By:
- Publication type:
- Article
Early Phase II Study of Uracil–Tegafur Plus Doxorubicin in Patients with Unresectable Advanced Biliary Tract Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2006, v. 36, n. 9, p. 552, doi. 10.1093/jjco/hyl075
- By:
- Publication type:
- Article
Phase I Study of Fixed Dose Rate Infusion of Gemcitabine in Patients with Unresectable Pancreatic Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2005, v. 35, n. 12, p. 733, doi. 10.1093/jjco/hyi190
- By:
- Publication type:
- Article
Phase I/II study of gemcitabine as a fixed dose rate infusion and S-1 combination therapy (FGS) in gemcitabine-refractory pancreatic cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 4, p. 957, doi. 10.1007/s00280-011-1786-6
- By:
- Publication type:
- Article
A phase II study of induction chemotherapy with gemcitabine plus S-1 followed by chemoradiotherapy for locally advanced pancreatic cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 3, p. 527, doi. 10.1007/s00280-009-1193-4
- By:
- Publication type:
- Article
A phase II study of S-1 in gemcitabine-refractory metastatic pancreatic cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 2, p. 313, doi. 10.1007/s00280-008-0741-7
- By:
- Publication type:
- Article
Neural invasion induces cachexia via astrocytic activation of neural route in pancreatic cancer.
- Published in:
- International Journal of Cancer, 2012, v. 131, n. 12, p. 2795, doi. 10.1002/ijc.27594
- By:
- Publication type:
- Article
Borderline resectable pancreatic cancer: rationale for multidisciplinary treatment.
- Published in:
- Journal of Hepato -- Biliary -- Pancreatic Sciences, 2011, v. 18, n. 4, p. 567, doi. 10.1007/s00534-011-0371-z
- By:
- Publication type:
- Article
Peretinoin after curative therapy of hepatitis C-related hepatocellular carcinoma: a randomized double-blind placebo-controlled study.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Peretinoin after curative therapy of hepatitis C-related hepatocellular carcinoma: a randomized double-blind placebo-controlled study.
- Published in:
- Journal of Gastroenterology, 2015, v. 50, n. 2, p. 191, doi. 10.1007/s00535-014-0956-9
- By:
- Publication type:
- Article
Serum HER2 as an adjunct to assess HER2 status for advanced gastric cancer: A prospective multicenter trial (SHERLOCK).
- Published in:
- Acta Oncologica, 2016, v. 55, n. 3, p. 309, doi. 10.3109/0284186X.2015.1107189
- By:
- Publication type:
- Article
Treatment Efficacy/Safety and Prognostic Factors in Patients with Advanced Biliary Tract Cancer Receiving Gemcitabine Monotherapy: An Analysis of 100 Cases.
- Published in:
- Oncology, 2010, v. 79, n. 1/2, p. 39, doi. 10.1159/000318020
- By:
- Publication type:
- Article
A Phase I Study of Combination Chemotherapy with Gemcitabine and Oral S-1 for Advanced Pancreatic Cancer.
- Published in:
- Oncology, 2005, v. 69, n. 5, p. 421, doi. 10.1159/000089997
- By:
- Publication type:
- Article
Phase I study of combination chemotherapy using sorafenib and transcatheter arterial infusion with cisplatin for advanced hepatocellular carcinoma.
- Published in:
- Cancer Science, 2014, v. 105, n. 3, p. 354, doi. 10.1111/cas.12353
- By:
- Publication type:
- Article
Phase II study of erlotinib plus gemcitabine in Japanese patients with unresectable pancreatic cancer.
- Published in:
- Cancer Science, 2011, v. 102, n. 2, p. 425, doi. 10.1111/j.1349-7006.2010.01810.x
- By:
- Publication type:
- Article
Phase I/II study of the pharmacokinetics, safety and efficacy of S-1 in patients with advanced hepatocellular carcinoma Furuse et al.
- Published in:
- Cancer Science, 2010, v. 101, n. 12, p. 2606, doi. 10.1111/j.1349-7006.2010.01730.x
- By:
- Publication type:
- Article
Phase I study of sorafenib in Japanese patients with hepatocellular carcinoma.
- Published in:
- Cancer Science, 2008, v. 99, n. 1, p. 159, doi. 10.1111/j.1349-7006.2007.00648.x
- By:
- Publication type:
- Article